Developing the COVID-19 vaccine: The trials and challenges
The Agenda

Translating...

Content is automatically generated by Microsoft Azure Translator Text API. CGTN is not responsible for any of the translations.

Error loading player: No playable sources found
08:01

Fewer than a dozen COVID-19 vaccines around the world have now reached the phase three stage, which means they are being trialled in human volunteers. 

One is made by Sinovac, a China-based biopharmaceutical company, which is conducting human trials in Brazil, Turkey and Indonesia.

Helen Yang, Senior Director of Global Strategy and Business Development at Sinovac tells The Agenda with Stephen Cole that the firm is expecting the first set of useful data from these trials by the end of November or early December. 

Yang says cooperation will be key for it to be a success as, "Only a global partnership can make things happen."

MORE FROM CGTN
{"type":2,"value":"The Agenda","commentator":[],"valueShow":true,"commentatorShow":false}

The Agenda

14:58, 19-Jul-2025

Tourist coins pose giant problem at N. Ireland's famous causeway site
{"type":2,"value":"CGTN","commentator":[],"valueShow":true,"commentatorShow":false}

Europe

14:57, 19-Jul-2025

Passion for hand fans sizzles in burning Spanish heat
{"type":2,"value":"CGTN","commentator":[],"valueShow":true,"commentatorShow":false}

Europe

11:31, 19-Jul-2025

{"type":2,"value":"CGTN","commentator":[],"valueShow":true,"commentatorShow":false}

Europe

16:09, 18-Jul-2025

TOP NEWS
Xi, Mauritanian president exchange congratulations on 60 years of ties
{"type":2,"value":"CGTN","commentator":[],"valueShow":true,"commentatorShow":false}

Politics

06:45, 19-Jul-2025

China unveils new measures to boost foreign reinvestment
{"type":2,"value":"CGTN","commentator":[],"valueShow":true,"commentatorShow":false}

Economy

05:54, 19-Jul-2025

Israeli, Syrian leaders agree to ceasefire as clashes rock Sweida
{"type":2,"value":"CGTN","commentator":[],"valueShow":true,"commentatorShow":false}

Middle East

22:49, 18-Jul-2025